Neurogene Inc. (NGNE) Net Margin
- 2024-06-30: Net Margin -1999.14%.
- 2018-06-30: Net Margin 11.67%.
Complete source-backed net margin history.
- Available history
- 2018-06-30 to 2024-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2024-06-30 | -1999.14% |
| 2018-06-30 | 11.67% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | -8123.68% |
| 2018-12-31 | -126.34% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |